U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad

Outlet: The Hindu · Published 24/10/2026 05:38 UTC

Only The Hindu reports this: no contrast yet

None of the other outlets we follow has reported this story, so there are no versions to compare. If others publish it or data appear that test it, it will move to the comparison.

The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23

Read on the original outlet ↗

Capture record

Source: https://www.thehindu.com/business/Industry/us-fda-issues-four-observations-to-gland-pharma-formulation-facility-near-hyderabad/article71616791.ece
Published: 24/10/2026 05:38 UTC
Captured: 24/10/2026 06:09 UTC
Text fingerprint: 4f87f8fb08730c2b · 110 words
Changes detected: 0
Archived copy: Wayback Machine ↗

The fingerprint (sha256) and the capture date prove what the story said when we analysed it, even if it changes later.